Search Results for "Tingkatan Satu Sejarah Nota"
Matching Channels
None
Matching News
ValiRx well-positioned to feed Big Pharma
Dr Satu Vainikka, CEO of ValiRx (LON:VAL), tells Proactiveinvestors that good clinical progress is being made with VAL201, the company's prostate cancer drug. The company's cash position is good, and...
ValiRx: shares rise 40% on new study of VAL201
Dr Satu Vainikka, CEO of ValiRx (LON:VAL), tells Proactiveinvestors that this independent study is “excellent news” and takes forward initial findings on the abilities of anti-cancer compound VAL2...
Atlanta, GA, Oct. 22, 2012 (GLOBE NEWSWIRE) -- Invoiceware International extends their SAP® ERP Compliance Dashboards for Brazil to support the new processes for Nota Fiscal cancellations as well...
Atlanta, GA, March 19, 2013 (GLOBE NEWSWIRE) -- Invoiceware International extends their SAP ERP Rapid Deployment Templates to manage Brazil's new processes for Nota Fiscal cancellations, the entire...
Atlanta, GA, Dec. 4, 2012 (GLOBE NEWSWIRE) -- Brown-Forman, one of the top 10 largest global spirits companies, utilizes the Invoiceware International network to manage their electronic invoicing pro...
ValiRx appoints chief commercial officer
Drug developer and diagnostics specialist ValiRx (LON:VAL) has appointed a chief commercial officer. He is Samuel Ogunsalu, former head of commercialisation and the sector specialist for life science...
ValiRx granted patent in Australia for top compound
ValiRx (LON:VAL) has been granted patent protection in Australia for VAL201, its lead therapeutic compound that targets at a range of cancers. The company already has full, worldwide rights and contr...
ValiRx hopes to achieve some "momentous milestones"
Drug developer and diagnostics specialist ValiRx (LON:VAL) hopes to achiveve some "momentous milestones", it said, as it released final results. Chief executive Dr Satu Vainikka said the firm will co...
Matching PubMed Articles
Dissociation kinetics of Mn(2+) complexes of NOTA and DOTA.
The kinetics of transmetallation of [Mn(nota)](-) and [Mn(dota)](2-) was investigated in the presence of Zn(2+) (5-50-fold excess) at variable pH (3.5-5.6) by (1)H relaxometry. The dissociation is muc...
Radiolabeled nitroimidazole (NI) derivatives have been used for imaging hypoxic tissues. We synthesized NI derivatives conjugated with bifunctional chelating agents such as 1,4,7-triazacyclononane-1,4...
Evaluation of a Maleimido Derivative of NOTA for Site-Specific Labeling of Affibody Molecules.
Radionuclide molecular imaging has the potential to improve cancer treatment by selection of patients for targeted therapy. Affibody molecules are a class of small (7 kDa) high-affinity targeting prot...
(68)Ga Small Peptide Imaging: Comparison of NOTA and PCTA.
In this study, a bifunctional version of the chelate PCTA was compared to the analogous NOTA derivative for peptide conjugation, (68)Ga radiolabeling, and small peptide imaging. Both p-SCN-Bn-PCTA and...
[(18)F]FPPRGD2, an F-18 labeled dimeric cyclic RGDyK peptide, has favorable properties for PET imaging of angiogenesis by targeting the α(v)β(3) integrin receptor. This radiotracer has been approved...
